Verbatim response from Claude
Compounded Tirzepatide Availability
This is a nuanced situation that's been changing rapidly:
Current Status (as of early 2025)
The FDA declared the tirzepatide shortage resolved, which means most compounding pharmacies are required to stop making it. The FDA set a deadline that has largely passed for 503A and 503B compounders to wind down production.
What May Still Be Legitimate
- 503B outsourcing facilities may have limited transitional availability
- Some compounders are pursuing FDA-approved pathways for specific patient populations (documented allergies to inactive ingredients, specific dosing needs)
Reputable Sources to Check
- Hims & Hers - was offering compounded versions, check current status
- LifeMD/GoRx - similar telehealth model
- Belmar Pharmacy or Empower Pharmacy - 503A/503B compounders (verify current compliance)
⚠️ Important Cautions
- Avoid any gray-market or overseas sources
- The legal landscape is actively shifting - verify directly with providers
- Some telehealth companies are now pivoting to brand-name Zepbound (the weight loss indication)
My Honest Recommendation
Talk to a legitimate telehealth provider like Hims, LifeMD, or your own doctor about Zepbound (brand tirzepatide), as manufacturer savings programs can significantly reduce cost.
Want help finding cost-reduction options for brand-name tirzepatide?